Urinary Incontinence Botox Treatment Adana Bladder Botox

What is Bladder Botox (Botulinum Toxin) Treatment for Urinary Incontinence?

Bladder Botox injection is an advanced, minimally invasive treatment option for patients suffering from overactive bladder (OAB) and urge urinary incontinence. Botulinum toxin is injected directly into the detrusor muscle of the bladder. By blocking the nerve signals that cause involuntary muscle contractions, it relaxes the bladder wall, increases storage capacity, and reduces sudden, uncontrollable urges to urinate.

When is Bladder Botox Indicated?

This procedure is typically recommended for patients who have not achieved adequate relief from conservative treatments. The primary indications include:

• Overactive bladder syndrome resistant to oral medications
• Urge urinary incontinence (leakage accompanied by a sudden urge)
• Neurogenic detrusor overactivity (due to spinal cord injury, Multiple Sclerosis, or Parkinson's disease)
• Severe frequency and urgency affecting daily quality of life

How is Bladder Botox Performed in Adana?

The procedure is carried out by urologists under sterile conditions, utilizing local anesthesia, sedation, or general anesthesia depending on patient preference. A thin, lighted instrument called a cystoscope is inserted through the urethra into the bladder. Using a specialized needle, the botulinum toxin is precisely injected into 20 to 30 pre-determined sites in the bladder muscle. The entire process takes approximately 15 to 20 minutes, and patients are usually discharged on the same day.

Advantages and Duration of Efficacy

The key benefit of bladder Botox is its high success rate without the need for major surgery. The therapeutic effects generally begin to manifest within 7 to 14 days post-injection. The clinical benefits typically last between 6 to 9 months. Once the effect wears off, the treatment can be safely repeated to maintain bladder control.

Post-Procedure Care and Potential Risks

Patients are advised to increase fluid intake for a few days following the procedure. Mild dysuria (burning sensation during urination) or transient hematuria (blood in the urine) may occur and usually resolves spontaneously. A temporary risk of urinary retention (inability to empty the bladder completely) exists in a small percentage of patients, which is managed with temporary catheterization. A urine culture must be performed before the procedure to rule out active urinary tract infections.